Construction and evaluation in vitro and in vivo of tedizolid phosphate loaded cationic liposomes

References

• Alhariri, M., Azghani, A., and Omri, A., 2013. Liposomal antibiotics for the treatment of infectious diseases. Expert Opinion on Drug Delivery, 10 (11), 1515–1532.
   PubMed Web of Science ®Google Scholar
• Alipour, M., et al., 2008. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. International Journal of Pharmaceutics, 355 (1), 293–298.
   PubMed Web of Science ®Google Scholar
• Anwekar, H., Patel, S., and Singhai, A.K., 2011. Liposome-as drug carriers. International Journal of Pharmacy and Life Sciences, 2 (7), 945–951.
   Google Scholar
• Aoki, H., et al., 1997. Effects of positive charge density on the liposomal surface on disposition kinetics of liposomes in rats. International Journal of Pharmaceutics, 156 (2), 163–174.
   Web of Science ®Google Scholar
• Bakker-Woudenberg, I.A., et al., 1986. Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages. Antimicrobial Agents and Chemotherapy, 30 (2), 295–300.
   PubMed Web of Science ®Google Scholar
• Bangham, A.D., Standish, M.M., and Watkins, J.C., 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology, 13 (1), 238–252.
   PubMed Web of Science ®Google Scholar
• Blume, G. and Cevc, G., 1990. Liposomes for the sustained drug release in vivo. Biochimica et Biophysica Acta, 1029 (1), 91–97.
   PubMed Web of Science ®Google Scholar
• Cryan, S.A., 2005. Carrier-based strategies for targeting protein and peptide drugs to the lungs. The AAPS Journal, 7 (1), E20–E41.
   PubMed Web of Science ®Google Scholar
• Cui, F. and Long, X., 2011. Pharmaceutics. 7th ed. Beijing: People’s Health Publishing House, 445–446.
   Google Scholar
• Dua, J.S., Rana, A.C., and Bhandari, A.K., 2012. Liposome: methods of preparation and applications. International Journal of Pharmaceutical Studies Research, 3 (2), 14–20.
   Google Scholar
• Düzgüneş, N., et al., 1988. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrobial Agents and Chemotherapy, 32 (9), 1404–1411.
   PubMed Web of Science ®Google Scholar
• Fan, M., et al., 2008. Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. European Food Research and Technology, 227 (1), 167–174.
   Web of Science ®Google Scholar
• Fujisawa, T., et al., 2012. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. International Journal of Pharmaceutics, 436 (1–2), 564–567.
   PubMed Web of Science ®Google Scholar
• Grit, M. and Crommelin, D.J.A., 1993. The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylglycerol in aqueous liposome dispersions. Biochimica Et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, 1167 (1), 49–55.
   PubMed Web of Science ®Google Scholar
• Huang, L., Sullenger, B., and Juliano, R., 2010. The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides. Journal of Drug Targeting, 18 (8), 567–574.
   PubMed Web of Science ®Google Scholar
• Hwang, S.H., et al., 1999. Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods. International Journal of Pharmaceutics, 179 (1), 85–95.
   PubMed Web of Science ®Google Scholar
• Isailović, B.D., et al., 2013. Resveratrol loaded liposomes produced by different techniques. Innovative Food Science & Emerging Technologies, 19, 181–189.
   Web of Science ®Google Scholar
• Kanafani, Z.A. and Corey, G.R., 2012. Tedizolid (TR-701): a new oxazolidinone with enhanced potency. Expert Opinion on Investigational Drugs, 21 (4), 515–522.
   PubMed Web of Science ®Google Scholar
• Kas, H.S., 1997. Chitosan: properties, preparations and application to microparticulate systems. Journal of Microencapsulation, 14 (6), 689–711.
   PubMed Web of Science ®Google Scholar
• Kellaway, I.W. and Farr, S.J., 1990. Liposomes as drug delivery systems to the lung. Advanced Drug Delivery Reviews, 5 (1–2), 149–161.
   Google Scholar
• Kshirsagar, N.A., et al., 2005. Liposomal drug delivery system from laboratory to clinic. Journal of Postgraduate Medicine, 51 (5), 5.
   Google Scholar
• Liu, J., et al., 2015. Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: characterization and evaluation. Asian Journal of Pharmaceutical Sciences, 10 (3), 212–222.
   Web of Science ®Google Scholar
• Onyeji, C.O., et al., 1995. Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. The Journal of Infectious Diseases, 172 (3), 810–816.
   PubMed Web of Science ®Google Scholar
• Pinto-Alphandary, H., Andremont, A., and Couvreur, P., 2000. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. International Journal of Antimicrobial Agents, 13 (3), 155–168.
   PubMed Web of Science ®Google Scholar
• Prokocimer, P., et al., 2013. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA, 309 (6), 559–569.
   PubMed Web of Science ®Google Scholar
• Rybak, J.M. and Roberts, K., 2015. Tedizolid phosphate: a next-generation oxazolidinone. Infectious Diseases and Therapy, 4 (1), 1–14.
   PubMed Web of Science ®Google Scholar
• Senior, J.H., 1986. Fate and behavior of liposomes in vivo: a review of controlling factors. Critical Reviews in Therapeutic Drug Carrier Systems, 3 (2), 123–193.
   Web of Science ®Google Scholar
• Shaw, K.J. and Barbachyn, M.R., 2011. The oxazolidinones: past, present, and future. Annals of the New York Academy of Sciences, 1241 (1), 48–70.
   PubMedGoogle Scholar
• Szoka, F. and Papahadjopoulos, D., 1978. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences of the United States of America, 75 (9), 4194–4198.
   PubMed Web of Science ®Google Scholar
• Thomson, K.S. and Goering, R.V., 2013. Activity of tedizolid (TR-700) against well-characterized MRSA strains of diverse epidemiological origin. Antimicrobial Agents and Chemotherapy, 57 (6), 2892–2895.
   PubMed Web of Science ®Google Scholar
• Tomioka, H., et al., 1991. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. American Journal of Respiratory and Critical Care Medicine, 144 (3), 575–579.
   Google Scholar
• Yang, Z., et al., 2015. Chitosan coated vancomycin hydrochloride liposomes: characterizations and evaluation. International Journal of Pharmaceutics, 495 (1), 508–515.
   PubMed Web of Science ®Google Scholar
• Yoo, J.W., Chambers, E., and Mitragotri, S., 2010. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Current Pharmaceutical Design, 16 (21), 2298–2307.
   PubMed Web of Science ®Google Scholar